{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:01:49Z","timestamp":1790413309011,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503308"],"award-info":[{"award-number":["81503308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673600"],"award-info":[{"award-number":["81673600"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473147"],"award-info":[{"award-number":["81473147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Administration of Traditional Chinese Medicine of Jiangsu Province","award":["YB2015007"],"award-info":[{"award-number":["YB2015007"]}]},{"name":"Top-notch Academic Programs Project of Jiangsu Higher Education Institutions","award":["PPZY2015A070"],"award-info":[{"award-number":["PPZY2015A070"]}]},{"name":"Top-notch Academic Programs Project of Jiangsu Higher Education Institutions","award":["TAPP"],"award-info":[{"award-number":["TAPP"]}]},{"name":"Postgraduate Research Innovation Project of Jiangsu Higher Education Institutions","award":["KYLX16_1160"],"award-info":[{"award-number":["KYLX16_1160"]}]},{"name":"Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions","award":["PAPD"],"award-info":[{"award-number":["PAPD"]}]},{"name":"Open Project Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine","award":["JKLPSE201608"],"award-info":[{"award-number":["JKLPSE201608"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12964-018-0217-2","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T09:23:00Z","timestamp":1517822580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Oxidative phosphorylation activation is an important characteristic of DOX resistance in hepatocellular carcinoma cells"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9380-8620","authenticated-orcid":false,"given":"Li","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"217_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd3137","volume":"9","author":"S Fulda","year":"2010","unstructured":"Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov. 2010;9:447\u201364.","journal-title":"Nat Rev Drug Discov"},{"key":"217_CR2","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1038\/sj.onc.1209602","volume":"25","author":"S Ohta","year":"2006","unstructured":"Ohta S. Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs. Oncogene. 2006;25:4768\u201376.","journal-title":"Oncogene"},{"key":"217_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1126\/science.68.1767.437","volume":"68","author":"O Warburg","year":"1928","unstructured":"Warburg O. The chemical constitution of respiration ferment. Science. 1928;68:437\u201343.","journal-title":"Science"},{"key":"217_CR4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8:1519\u201330.","journal-title":"J Gen Physiol"},{"key":"217_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2014.08.027","volume":"79","author":"X Chen","year":"2015","unstructured":"Chen X, Qian Y, Wu S. The Warburg effect: evolving interpretations of an established concept. Free Radic Biol Med. 2015;79:253\u201363.","journal-title":"Free Radic Biol Med"},{"key":"217_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2008.01.006","volume":"18","author":"V Gogvadze","year":"2008","unstructured":"Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol. 2008;18:165\u201373.","journal-title":"Trends Cell Biol"},{"key":"217_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.mito.2004.07.027","volume":"4","author":"JS Modica-Napolitano","year":"2004","unstructured":"Modica-Napolitano JS, Singh KK. Mitochondrial dysfunction in cancer. Mitochondrion. 2004;4:755\u201362.","journal-title":"Mitochondrion"},{"key":"217_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2006.04.023","volume":"9","author":"VR Fantin","year":"2006","unstructured":"Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006;9:425\u201334.","journal-title":"Cancer Cell"},{"key":"217_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"217_CR10","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/ijc.28935","volume":"135","author":"W Liu","year":"2014","unstructured":"Liu W, Li L, Li W. Gene co-expression analysis identifies common modules related to prognosis and drug resistance in cancer cell lines. Int J Cancer. 2014;135:2795\u2013803.","journal-title":"Int J Cancer"},{"key":"217_CR11","first-page":"755","volume":"2011","author":"A Mar\u00edn-Hern\u00e1ndez","year":"1807","unstructured":"Mar\u00edn-Hern\u00e1ndez A, Gallardo-P\u00e9rez JC, Rodr\u00edguez-Enr\u00edquez S, Encalada R, Moreno-Sanchez R, Saavedra E. Modeling cancer glycolysis. Biochim Biophys Acta. 1807;2011:755\u201367.","journal-title":"Biochim Biophys Acta"},{"key":"217_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/mc.20539","volume":"48","author":"D Loiseau","year":"2009","unstructured":"Loiseau D, Morvan D, Chevrollier A, Demidem A, Douay O, Reynier P, Stepien G. Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy. Mol Carcinog. 2009;48:733\u201341.","journal-title":"Mol Carcinog"},{"key":"217_CR13","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3390\/ijms13021933","volume":"13","author":"R Domenis","year":"2012","unstructured":"Domenis R, Bisetto E, Rossi D, Comelli M, Mavelli I. Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor factor 1. Int J Mol Sci. 2012;13:1933.","journal-title":"Int J Mol Sci"},{"key":"217_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1006\/abbi.1993.1397","volume":"305","author":"DJ Dietzen","year":"1993","unstructured":"Dietzen DJ, Davis EJ. Oxidation of pyruvate, malate, citrate, and cytosolic reducing equivalents by AS-30D hepatoma mitochondria. Arch Biochem Biophys. 1993;305:91\u2013102.","journal-title":"Arch Biochem Biophys"},{"key":"217_CR15","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","volume":"27","author":"R Moreno-S\u00e1nchez","year":"2007","unstructured":"Moreno-S\u00e1nchez R, Rodr\u00edguez-Enr\u00edquez S, Mar\u00edn-Hern\u00e1ndez A, Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007;27:1393\u2013418.","journal-title":"FEBS J"},{"key":"217_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/biof.31","volume":"35","author":"R Moreno-S\u00e1nchez","year":"2009","unstructured":"Moreno-S\u00e1nchez R, Rodr\u00edguez-Enr\u00edquez S, Saavedra E, Mar\u00edn-Hern\u00e1ndez A, Gallardo-P\u00e9rez JC. The bioenergetics of cancer: is glycolysis the main ATP supplier in all tumor cells? Biofactors. 2009;35:209\u201325.","journal-title":"Biofactors"},{"key":"217_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00204-012-0809-3","volume":"86","author":"A Mar\u00edn-Hern\u00e1ndez","year":"2012","unstructured":"Mar\u00edn-Hern\u00e1ndez A, Gallardo-P\u00e9rez JC, L\u00f3pez-Ram\u00edrez SY, Garc\u00eda-Garc\u00eda JD, Rodr\u00edguez-Zavala JS, Ruiz-Ram\u00edrez L, Gracia-Mora I, Zentella-Dehesa A, Sosa-Garrocho M, Mac\u00edas-Silva M, Moreno-S\u00e1nchez R, Rodr\u00edguez-Enr\u00edquez S. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation. Arch Toxicol. 2012;86:753\u201366.","journal-title":"Arch Toxicol"},{"key":"217_CR18","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/ncomms3508","volume":"4","author":"R Ma","year":"2013","unstructured":"Ma R, Zhang W, Tang K, Zhang H, Li D, Li Y, Xu P, Luo S, Cai W, Ji T, Katirai F, Ye D, Huang B. Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma. Nat Commun. 2013;4:2508.","journal-title":"Nat Commun"},{"key":"217_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10863-011-9380-5","volume":"43","author":"R Domenis","year":"2011","unstructured":"Domenis R, Comelli M, Bisetto E, Mavelli I. Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics. J Bioenerg Biomembr. 2011;43:493\u2013505.","journal-title":"J Bioenerg Biomembr"},{"key":"217_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3892\/mmr.2012.906","volume":"6","author":"JJ Lu","year":"2012","unstructured":"Lu JJ, Yang Z, Lu DZ, Wo XD, Shi JJ, Lin TQ, Wang MM, Li Y, Tang LH. Dihydroartemisinin-induced inhibition of proliferation in BEL-7402 cells: an analysis of the mitochondrial proteome. Mol Med Rep. 2012;6:429.","journal-title":"Mol Med Rep"},{"key":"217_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature13264","volume":"510","author":"RM Chin","year":"2014","unstructured":"Chin RM, Fu X, Pai MY, Vergnes L, Hwang H, Deng G, Diep S, Lomenick B, Meli VS, Monsalve GC, Hu E, Whelan SA, Wang JX, Jung G, Solis GM, Fazlollahi F, Kaweeteerawat C, Quach A, Nili M, Krall AS, Godwin HA, Chang HR, Faull KF, Guo F, Jiang M, Trauger SA, Saghatelian A, Braas D, Christofk HR, Clarke CF, Teitell MA, Petrascheck M, Reue K, Jung ME, Frand AR, Huang J. The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature. 2014;510:397\u2013401.","journal-title":"Nature"},{"key":"217_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10602","volume":"481","author":"CM Metallo","year":"2012","unstructured":"Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, Jewell CM, Johnson CR, Irvine DJ, Guarente L, Kelleher JK, Vander Heiden MG, Iliopoulos O, Stephanopoulos G. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature. 2012;481:380\u20134.","journal-title":"Nature"},{"key":"217_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nature10642","volume":"481","author":"AR Mullen","year":"2012","unstructured":"Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan M, Chandel NS, DeBerardinis RJ. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature. 2012;481:385\u20138.","journal-title":"Nature"},{"key":"217_CR24","doi-asserted-by":"publisher","first-page":"19611","DOI":"10.1073\/pnas.1117773108","volume":"108","author":"DR Wise","year":"2011","unstructured":"Wise DR, Ward PS, Shay JE, Cross JR, Gruber JJ, Sachdeva UM, Platt JM, Dematteo RG, Simon MC, Thompson CB. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A. 2011;108:19611\u20136.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-018-0217-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T19:41:16Z","timestamp":1549309276000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-018-0217-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1186\/s12964-018-0217-2","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"assertion":[{"value":"6 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"6"}}